New combo therapy tested for rare skin cancer
NCT ID NCT06235281
Summary
This small, early-stage study is testing whether combining a special light treatment (phototherapy) with the drug mogamulizumab works better for people with early-stage mycosis fungoides, a type of skin lymphoma. The goal is to see if this combination can better control the disease and reduce symptoms like itching. The study is currently suspended and will involve about 20 participants who have already tried other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYCOSIS FUNGOIDES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
Conditions
Explore the condition pages connected to this study.